Purpose: Age-related Macular Degeneration (AMD) is a severe neurodegenerative disease and a major cause of blindness in the elderly worldwide. Oxidative stress is a common feature of AMD pathogenesis, and a positive modulation of Nrf2 activity has been demonstrated to be protective. Natural products are generally a rich source of therapeutics; we recently combined polyphenols from curcumin and diallyl sulfide in new chemical entities to produce hybrids with anti-oxidant activity. To confirm Nrf2 pathway as a valuable therapeutic target, we studied the modulation of this cascade by our new hybrids. Methods: The human retinal pigment epithelium cell line ARPE-19 was exposed to increasing concentrations of the new nature-inspired hybrids. Cell viability was evaluated by MTT assay. Nrf2 nuclear translocation and target gene expression were measured by Western blotting. Results: New nature-inspired hybrids induce Nrf2 nuclear translocation and modulation of its target genes involved in phase II response in ARPE-19 cells. These molecules show a potency on Nrf2 activation profile comparable to that induced by the reference compounds curcumin and dimethylfumarate, the latter being currently used in clinic for multiple sclerosis. Conclusion: The new nature-inspired hybrids show to be promising to counteract some features related to AMD pathogenesis, thus suggesting the potential use of Nrf2 activators as therapeutics.

Nature-inspired Nrf2 activators in retinal pigment epithelial cells: a source for therapeutics in Age-related Macular Degeneration

AMADIO, MARIALAURA;SERAFINI, MELANIA MARIA;MARCHESI, NICOLETTA;CATANZARO, MICHELE;SIMONI, ELENA;PASCALE, ALESSIA ANGELA;LANNI, CRISTINA
2017

Abstract

Purpose: Age-related Macular Degeneration (AMD) is a severe neurodegenerative disease and a major cause of blindness in the elderly worldwide. Oxidative stress is a common feature of AMD pathogenesis, and a positive modulation of Nrf2 activity has been demonstrated to be protective. Natural products are generally a rich source of therapeutics; we recently combined polyphenols from curcumin and diallyl sulfide in new chemical entities to produce hybrids with anti-oxidant activity. To confirm Nrf2 pathway as a valuable therapeutic target, we studied the modulation of this cascade by our new hybrids. Methods: The human retinal pigment epithelium cell line ARPE-19 was exposed to increasing concentrations of the new nature-inspired hybrids. Cell viability was evaluated by MTT assay. Nrf2 nuclear translocation and target gene expression were measured by Western blotting. Results: New nature-inspired hybrids induce Nrf2 nuclear translocation and modulation of its target genes involved in phase II response in ARPE-19 cells. These molecules show a potency on Nrf2 activation profile comparable to that induced by the reference compounds curcumin and dimethylfumarate, the latter being currently used in clinic for multiple sclerosis. Conclusion: The new nature-inspired hybrids show to be promising to counteract some features related to AMD pathogenesis, thus suggesting the potential use of Nrf2 activators as therapeutics.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1190910
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact